Peter Hollander
Impact in
-
- Lymphoma Diagnosis and Treatment
-
- Viral-associated cancers and disorders
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Lymphoma Diagnosis and Treatment 22
- Oncology 7
- Viral-associated cancers and disorders 6
- Cancer Immunotherapy and Biomarkers 2
- Co-authors
- Rose‐Marie Amini (23 shared papers)Gunilla Enblad (19 shared papers)Ingrid Cecilia Glimelius (16 shared papers)Karin Ekstrom Ekstroem Smedby (8 shared papers)Daniel L. Molin (9 shared papers)Henrik Hjalgrim (6 shared papers)Christer Sundström (8 shared papers)Gustaf Hedström (3 shared papers)
In The Last Decade
Peter Hollander
28 papers receiving 340 citations
Peers
Comparison fields: 5 of 37
- Pathology and Forensic Medicine 214
- Oncology 76
- Immunology 49
- Biological Psychiatry 2
- Hematology 13
Countries citing papers authored by Peter Hollander
This map shows the geographic impact of Peter Hollander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Hollander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Hollander more than expected).
Fields of papers citing papers by Peter Hollander
This network shows the impact of papers produced by Peter Hollander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Hollander. The network helps show where Peter Hollander may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Hollander, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 42 | |
| 2 | 2019 | 32 | |
| 3 | 2018 | 26 | |
| 4 | 2021 | 26 | |
| 5 | 2017 | 25 | |
| 6 | 2015 | 24 | |
| 7 | 2018 | 19 | |
| 8 | 2019 | 19 | |
| 9 | 2022 | 18 | |
| 10 | 2021 | 17 | |
| 11 | 2021 | 15 | |
| 12 | 2020 | 12 | |
| 13 | 2023 | 10 | |
| 14 | 2020 | 9 | |
| 15 | 2021 | 9 | |
| 16 | High Expression Of Programmed Cell Death Receptor 1 In The Tumor Microenvironment Is Associated With Inferior Event Free Survival In Classical Hodgkin Lymphoma | 2016 | 6 |
| 17 | 2023 | 6 | |
| 18 | 2019 | 5 | |
| 19 | 2022 | 5 | |
| 20 | 2021 | 4 |
About Peter Hollander
Peter Hollander is a scholar working on Pathology and Forensic Medicine, Oncology, Immunology, Neurology and Hematology, having authored 29 papers that have together received 342 indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (22 papers), Viral-associated cancers and disorders (6 papers), Cancer Immunotherapy and Biomarkers (2 papers), Lymphadenopathy Diagnosis and Analysis (2 papers), T-cell and B-cell Immunology (2 papers), CNS Lymphoma Diagnosis and Treatment (2 papers), Acute Myeloid Leukemia Research (1 paper) and Phagocytosis and Immune Regulation (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (214 citations), Oncology (76 citations), Immunology (49 citations), Biological Psychiatry (2 citations) and Hematology (13 citations). Peter Hollander has collaborated with scholars based in Sweden, Denmark and Norway. Frequent co-authors include Rose‐Marie Amini, Gunilla Enblad, Ingrid Cecilia Glimelius, Karin Ekstrom Ekstroem Smedby, Daniel L. Molin, Henrik Hjalgrim, Christer Sundström, Gustaf Hedström, Klaus Rostgaard and Peter de Nully Brown. Their work appears in journals such as British Journal of Haematology, Blood Advances, Acta Oncologica, American Journal of Hematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.